Results 111 to 120 of about 7,742 (169)

Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine resistance

open access: yes, 2007
In vitro pyrimethamine response of Plastnodium fulciparum isolates and dihydrofolate reductase (dhfr) gene sequences were analyzed in 2004-2005 and compared with our previous data.
Tahar, Rachida, Basco, Leonardo K.
core  

Megaloblastic anaemie due to pyrimethamine

open access: yes, 1993
XXII. Ulusal Hematoloji Kongresinde tebliğ edildi. 21-25 Ekim 1991; İstanbul.Toksoplazmozis tanısıyla pyrimethamine tedavisi uygulanan hasta, anemi ve hemorajik diyatez bulgularıyla müracaat etti.

core  

Amodiaquine, Sulfadoxine/Pyrimethamine, and Combination Therapy for Treatment of Uncomplicated Falciparum Malaria in Kampala, Uganda: A Randomised Trial

open access: yesLancet, The, 2001
BACKGROUND: Increasing Plasmodium falciparum resistance to chloroquine in sub-Saharan Africa necessitates use of alternative antimalarial agents. Affordable alternative treatments include sulfadoxine/pyrimethamine and amodiaquine.
Grace Ndeezi   +2 more
exaly   +2 more sources

Chemoprevention by Pyrimethamine

Immunopharmacology and Immunotoxicology, 2005
The goal of the current research was to investigate the chemopreventive potency of an antimalaria drug, pyrimethamine, in in vitro conditions. The fibrosarcoma (WEHI-164) cell line was used for evaluating cytotoxicity, matrix metalloproteinase 2 (MMP-2) activity, and apoptosis. Pyrimethamine and methotrexate were used at concentrations of 0-8 microg/ml
Farshid, Saadat   +2 more
openaire   +2 more sources

Susceptibility of Plasmodium falciparum to Pyrimethamine and Sulfadoxine/Pyrimethamine in Kisumu, Kenya.

Lancet, The, 1982
Field studies were conducted in Kisumu, Kenya, to assess the susceptibility of local strains of Plasmodium falciparum to pyrimethamine alone (by a standard 7-day in-vivo test and a 48 h in-vitro field test) and to sulfadoxine-pyrimethamine (by a 7-day in-vivo test).
Phuc Nguyen-Dinh   +2 more
exaly   +3 more sources

Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1979
The effect of pyrimethamine and the combination of pyrimethamine-sulfadoxine (Fansidar) upon the termination of the acute attack of vivax malaria was studied in Thailand. Pyrimethamine was found to be ineffective, providing clearance of parasitaemia in only two of six patients by the end of seven days following treatment.
E B, Doberstyn   +4 more
openaire   +2 more sources

Pyrimethamine

2000
Abstract Pyrimethamine, an amyl analog of 2,4-diaminopyrimidine, is used in treatment and prophylaxis of toxoplasmosis and malaria; it is usually employed in combination with sulfon amides or sulfones. Pyrimethamine inhibits difolatereduc tase of microorganisms and prevents nuclear division dur ing mitosis; this inhibition occurs at ...
openaire   +1 more source

Teratogenicity of Pyrimethamine.

Lancet, The, 1983
Jean-Paul Harpey   +2 more
exaly   +2 more sources

Pyrimethamine

Reactions, 1983
Mohammed A. Loutfy   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy